The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Open accessAbstract
The lymphatic system plays a crucial role in the immune system’s recognition and response to disease, and most solid cancers initially spread from the primary site via the tumor’s surrounding lymphatics before hematological dissemination. Hence, the lymphatic system is an important target for developing new vaccines, cancer treatments, and diagnostic agents. Targeting the lymphatic system by subcutaneous, intestinal, and pulmonary routes has been evaluated and subsequently utilized to improve lymphatic penetration and retention of drug molecules, reduce drug-related systemic toxicities, and enhance bioavailability of poorly soluble and unstable drugs. Lymphatic imaging is an essential tool for the detection and staging of cancer. New nano-based technologies offer improved detection and characterization of the nodal diseases, while new delivery devices can better target and confine treatments to tumors within the nodal space while sparing healthy tissues. This manuscript reviews recent advances in the field of lymphatic drug delivery and imaging and focuses specifically on the development ofliposomes and solid lipid nanoparticles for lymphatic introduction via the subcutaneous, intestinal, and pulmonary routes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.
Oussoren, C., Zuidema, J., Crommelin, D. J. A., & Storm, G. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00122-3 · Cited by 380
Paliwal, R., Rai, S., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
Charman, W. N., & Stella, V. J. (2019) · Routledge eBooks · doi:10.1201/9780203748572 · Cited by 195
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Frenkel, V., Etherington, A., Greene, M., Quijano, J., Xie, J., Hunter, F., Dromi, S. A., & Li, K. C. (2006) · Academic Radiology · doi:10.1016/j.acra.2005.08.024 · Cited by 148
Soundararajan, A., Bao, A., Phillips, W. T., Perez, R., & Goins, B. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.02.004 · Cited by 145
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Baboota, S., Shah, F. M., Javed, A., & Alka, A. (2009) · Journal of drug targeting · doi:10.1080/10611860902718672 · Cited by 128
de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 127
Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer
Tejada‐Berges, T., Granai, C. O., Gordinier, M. E., & Gajewski, W. H. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.2.143 · Cited by 118
Trubetskoy, V. S., Cannillo, J. A., Milshtein, A., Wolf, G. L., & Torchilin, V. P. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(94)00083-f · Cited by 98
Ling, S. S. N., Magosso, E., Khan, N. A. K., Yuen, K. H., & Barker, S. A. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500519102 · Cited by 93
Mui, B. L., Raney, S. G., Semple, S. C., & Hope, M. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29491-x · Cited by 90
Moghimi, S. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.082 · Cited by 84
Novel Method of Greatly Enhanced Delivery of Liposomes to Lymph Nodes
Phillips, W. T., Klipper, R. W., & Goins, B. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38903-7 · Cited by 71
Kojima, N., Biao, L., Nakayama, T., Ishii, M., Ikehara, Y., & Tsujimura, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.023 · Cited by 69
Lawson, K. A., Anderson, K., Snyder, R. M., Simmons-Menchaca, M., Atkinson, J., Sun, L., Bandyopadhyay, A. M., Knight, V., Gilbert, B. E., Sanders, B. G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0817-y · Cited by 62
Cavalli, R., Zara, G. P., Caputo, O., et al. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0737 · Cited by 57
Neidhart, J. D., Allen, K. O., Barlow, D. L., Carpenter, M., Shaw, D. R., Triozzi, P. L., & Conry, R. M. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.021 · Cited by 55
Cui, Z., Han, S., & Huang, L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029292.66792.4f · Cited by 55
Latimer, P., Simmons-Menchaca, M., Snyder, R. M., Yu, W., Gilbert, B. E., Sanders, B. G., & Kline, K. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-rm-8 · Cited by 47
Bestman‐Smith, J., Gourde, P., Désormeaux, A., Tremblay, M. J., & Bergeron, M. G. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00254-6 · Cited by 41
Medina, L. A., Calixto, S. M., Klipper, R. W., Phillips, W. T., & Goins, B. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20163 · Cited by 37
Lymphoid Tissue Targeting of Anti-HIV Drugs Using Liposomes
Désormeaux, A., & Bergeron, M. G. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91019-7 · Cited by 35
Fujimoto, Y., Okuhata, Y., TYNGI, S., Namba, Y., & Oku, N. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.97 · Cited by 34
Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood
Trubetskoy, V. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00104-1 · Cited by 30
Moghimi, S. M., & Moghimi, M. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.033 · Cited by 27
Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model
Ling, R., Li, Y., Yao, Q., Chen, T., Zhu, D., Jun, Y., & Chen, J. (2005) · Journal of drug targeting · doi:10.1080/10611860400027725 · Cited by 18
ASSESSMENT OF LIPOSOME DELIVERY USING SCINTIGRAPHIC IMAGING
Phillips, W. T., & Goins, B. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004779 · Cited by 13
Medina, L. A., Calixto, S. M., Klipper, R. W., Li, Y., Phillips, W. T., & Goins, B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20516 · Cited by 11
Progression of Clinically Stable Lymphedema on Lymphoscintigraphy
Luongo, J. A., Scalcione, L. R., Katz, D. S., & Yung, E. Y.-K. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181b06cc5 · Cited by 5
Cited by
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
Hanson, M. C., Crespo, M. P., Abraham, W., Moynihan, K. D., Szeto, G. L., Chen, S. H., Melo, M. B., Mueller, S., & Irvine, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79915 · Cited by 381
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 357
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 346
Three decades of messenger RNA vaccine development
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41521 · Cited by 333
Metadata
- Authors
- Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 63
- Issue
- 10-11
- Pages
- 901-908
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1989680746
- Cited by
- 252
- References
- 41
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.